These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 8886398)

  • 21. Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo.
    Parsons CG; Quack G; Bresink I; Baran L; Przegalinski E; Kostowski W; Krzascik P; Hartmann S; Danysz W
    Neuropharmacology; 1995 Oct; 34(10):1239-58. PubMed ID: 8570022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional in vitro characterization of CR 3394: a novel voltage dependent N-methyl-D-aspartate (NMDA) receptor antagonist.
    Losi G; Lanza M; Makovec F; Artusi R; Caselli G; Puia G
    Neuropharmacology; 2006 Mar; 50(3):277-85. PubMed ID: 16236334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-channel activations and concentration jumps: comparison of recombinant NR1a/NR2A and NR1a/NR2D NMDA receptors.
    Wyllie DJ; Béhé P; Colquhoun D
    J Physiol; 1998 Jul; 510 ( Pt 1)(Pt 1):1-18. PubMed ID: 9625862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition.
    Laurie DJ; Seeburg PH
    Eur J Pharmacol; 1994 Aug; 268(3):335-45. PubMed ID: 7528680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism.
    Chen HS; Lipton SA
    J Physiol; 1997 Feb; 499 ( Pt 1)(Pt 1):27-46. PubMed ID: 9061638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms intrinsic to 5-HT2B receptor-induced potentiation of NMDA receptor responses in frog motoneurones.
    Holohean AM; Hackman JC
    Br J Pharmacol; 2004 Oct; 143(3):351-60. PubMed ID: 15339859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subtype-selective antagonism of N-methyl-D-aspartate receptor ion channels by synthetic conantokin peptides.
    Sheng Z; Dai Q; Prorok M; Castellino FJ
    Neuropharmacology; 2007 Jul; 53(1):145-56. PubMed ID: 17588620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes.
    Buller AL; Monaghan DT
    Eur J Pharmacol; 1997 Feb; 320(1):87-94. PubMed ID: 9049607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of glutamate binding sites in receptors assembled from transfected NMDA receptor subunits.
    Kendrick SJ; Lynch DR; Pritchett DB
    J Neurochem; 1996 Aug; 67(2):608-16. PubMed ID: 8764586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonist concentration dependency of blocking kinetics but not equilibrium block of N-methyl-D-aspartate receptors by memantine.
    Gilling KE; Jatzke C; Parsons CG
    Neuropharmacology; 2007 Sep; 53(3):415-20. PubMed ID: 17632186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of 45Ca2+ influx into cells stably expressing recombinant human NMDA receptors by ligands acting at distinct recognition sites.
    Grimwood S; Gilbert E; Ragan CI; Hutson PH
    J Neurochem; 1996 Jun; 66(6):2589-95. PubMed ID: 8632186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-channel currents from recombinant NMDA NR1a/NR2D receptors expressed in Xenopus oocytes.
    Wyllie DJ; Béhé P; Nassar M; Schoepfer R; Colquhoun D
    Proc Biol Sci; 1996 Aug; 263(1373):1079-86. PubMed ID: 8805841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ca2+ inhibits the association of memantine with N-methyl-D-aspartate (NMDA) receptor-gated ion channels.
    Fujimoto M; Iida H; Homma T; Kimura I; Mori M; Hamana H
    Biol Pharm Bull; 2008 Sep; 31(9):1813-5. PubMed ID: 18758084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition.
    Chen N; Moshaver A; Raymond LA
    Mol Pharmacol; 1997 Jun; 51(6):1015-23. PubMed ID: 9187268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of a threonine residue in the S2 ligand binding domain in determining agonist potency and deactivation rate of recombinant NR1a/NR2D NMDA receptors.
    Chen PE; Johnston AR; Mok MH; Schoepfer R; Wyllie DJ
    J Physiol; 2004 Jul; 558(Pt 1):45-58. PubMed ID: 15107472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
    Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
    Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of c-Src tyrosine kinase on ethanol sensitivity of recombinant NMDA receptors expressed in HEK 293 cells.
    Anders DL; Blevins T; Sutton G; Chandler LJ; Woodward JJ
    Alcohol Clin Exp Res; 1999 Feb; 23(2):357-62. PubMed ID: 10069568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Memantine selectively blocks extrasynaptic NMDA receptors in rat substantia nigra dopamine neurons.
    Wu YN; Johnson SW
    Brain Res; 2015 Apr; 1603():1-7. PubMed ID: 25656790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation and characterisation of stable cell lines expressing recombinant human N-methyl-D-aspartate receptor subtypes.
    Grimwood S; Le Bourdellès B; Atack JR; Barton C; Cockett W; Cook SM; Gilbert E; Hutson PH; McKernan RM; Myers J; Ragan CI; Wingrove PB; Whiting PJ
    J Neurochem; 1996 Jun; 66(6):2239-47. PubMed ID: 8632144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NMDA receptors mediate neuron-to-glia signaling in mouse cortical astrocytes.
    Lalo U; Pankratov Y; Kirchhoff F; North RA; Verkhratsky A
    J Neurosci; 2006 Mar; 26(10):2673-83. PubMed ID: 16525046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.